NIKOLA CORP (NKLA)

US6541101050 - Common Stock

0.49  -0.02 (-3.33%)

After market: 0.49 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NKLA. NKLA was compared to 130 industry peers in the Machinery industry. NKLA may be in some trouble as it scores bad on both profitability and health. NKLA is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

NKLA had negative earnings in the past year.
In the past year NKLA has reported a negative cash flow from operations.
NKLA had negative earnings in 4 of the past 5 years.
NKLA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

NKLA has a Return On Assets of -82.01%. This is amonst the worse of the industry: NKLA underperforms 91.41% of its industry peers.
NKLA has a Return On Equity of -161.17%. This is amonst the worse of the industry: NKLA underperforms 89.84% of its industry peers.
Industry RankSector Rank
ROA -82.01%
ROE -161.17%
ROIC N/A
ROA(3y)-69.65%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.18%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NKLA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

NKLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
NKLA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NKLA has more shares outstanding
NKLA has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -4.78, we must say that NKLA is in the distress zone and has some risk of bankruptcy.
NKLA has a Altman-Z score of -4.78. This is amonst the worse of the industry: NKLA underperforms 89.84% of its industry peers.
NKLA has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NKLA (0.46) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -4.78
ROIC/WACCN/A
WACC7.7%

2.3 Liquidity

A Current Ratio of 1.73 indicates that NKLA should not have too much problems paying its short term obligations.
With a Current ratio value of 1.73, NKLA is not doing good in the industry: 66.41% of the companies in the same industry are doing better.
A Quick Ratio of 1.50 indicates that NKLA should not have too much problems paying its short term obligations.
NKLA has a Quick ratio of 1.50. This is in the better half of the industry: NKLA outperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.5

6

3. Growth

3.1 Past

NKLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.66%, which is quite impressive.
NKLA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -45.61%.
Measured over the past years, NKLA shows a very strong growth in Revenue. The Revenue has been growing by 610.32% on average per year.
EPS 1Y (TTM)39.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.38%
Revenue 1Y (TTM)-45.61%
Revenue growth 3Y610.32%
Revenue growth 5YN/A
Sales Q2Q%-32.56%

3.2 Future

Based on estimates for the next years, NKLA will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.54% on average per year.
NKLA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 158.27% yearly.
EPS Next Y57.6%
EPS Next 2Y28.69%
EPS Next 3Y22.38%
EPS Next 5Y15.54%
Revenue Next Year216.28%
Revenue Next 2Y233.75%
Revenue Next 3Y208.25%
Revenue Next 5Y158.27%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NKLA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NKLA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NKLA's earnings are expected to grow with 22.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.69%
EPS Next 3Y22.38%

0

5. Dividend

5.1 Amount

NKLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NIKOLA CORP

NASDAQ:NKLA (6/17/2024, 5:02:54 PM)

After market: 0.49 0 (0%)

0.49

-0.02 (-3.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap664.71M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.01%
ROE -161.17%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.73
Quick Ratio 1.5
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)39.66%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y57.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-45.61%
Revenue growth 3Y610.32%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y